Vasovagal syncope
ICD-10 R55 · ICD-11 MG45.Z

Vasovagal Syncope in Adults Over 40 with Documented Asystolic Pauses — When Lifestyle Measures Have Not Reduced Recurrences

This protocol applies to patients aged over 40 years with vasovagal syncope characterised by objective evidence of significant asystolic pauses or specific cardioinhibitory patterns, in whom initial conservative management did not achieve a meaningful reduction in syncopal recurrences.

Clinical Scenario

Treatment Approach (Partial)

In highly selected patients meeting these criteria, a form of cardiac pacing is considered as a last-resort option. The complete protocol also specifies additional measures for patients with concurrent hypotensive susceptibility. The full sequence, patient-selection criteria, and any adjunctive steps are detailed in the structured regimen.

Clinical Goal

Reduction of syncope recurrence.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/eurheartj/ehy037

Cardiac pacing should be considered to reduce syncopal recurrences in patients aged >40 years, with spontaneous documented symptomatic asystolic pause(s) >3 s or asymptomatic pause(s) >6 s due to sinus arrest, AV block, or the combination of the two.
Cardiac pacing should be considered to reduce syncope recurrence in patients with cardioinhibitory carotid sinus syndrome who are >40 years with recurrent frequent unpredictable syncope.
Cardiac pacing may be considered to reduce syncope recurrences in patients with tilt-induced asystolic response who are >40 years with recurrent frequent unpredictable syncope.
Cardiac pacing may be considered to reduce syncope recurrences in patients with the clinical features of adenosine-sensitive syncope.
There is sufficient evidence that dual-chamber cardiac pacing should be considered to reduce recurrence of syncope when the correlation between symptoms and ECG is established in patients 40 years of age with the clinical features of those in the ISSUE studies.
Despite the lack of large RCTs, there is sufficient evidence that dual-chamber cardiac pacing should be considered to reduce syncopal recurrences in patients affected by dominant cardioinhibitory CSS.
Patients with hypotensive susceptibility should need measures directed to counteract hypotensive susceptibility in addition to cardiac pacing, e.g. the discontinuation/reduction of hypotensive drugs and the administration of fludrocortisone or midodrine.
View source ↗